Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Karyopharm Therapeutics Inc (NASDAQ:KPTI)

7.36
Delayed Data
As of Jul 28
 -0.31 / -4.04%
Today’s Change
4.83
Today|||52-Week Range
22.61
-44.45%
Year-to-Date
No recent news for Karyopharm Therapeutics Inc.

Today’s Trading

Previous close7.67
Today’s open7.68
Day’s range7.24 - 7.68
Volume54,086
Average volume (3 months)204,093
Market cap$275.8M
Dividend yield--
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-36.63%
Earnings growth (this year)+10.94%
Earnings growth (next 5 years)-13.68%
Revenue growth (last year)+9.17%
P/E ratioNM
Price/Sales1,887.83
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...-0.39-2.50%
CRHMCRH Medical Corp+0.42+11.11%
CRVSCorvus Pharmaceutica...-0.21-1.60%
PRTKParatek Pharmaceutic...-0.02-0.15%
Data as of 4:02pm ET, 07/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$250.0K
Annual profit (last year)-$118.2M
Net profit margin-47,272.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts

Partner Offers

Search for Jobs